Ligand validation:6BDR

A3P: ADENOSINE-3'-5'-DIPHOSPHATE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6BDR_A3P_A_301	99%	41%	0.059	0.995	1.07	1.2	2	3	0	0	100%	1
6BDS_A3P_A_301	100%	41%	0.041	0.993	1	1.3	1	5	0	0	100%	1
6UUX_A3P_A_301	100%	40%	0.048	0.989	1.1	1.25	3	2	0	0	100%	1
8E5Q_A3P_A_402	99%	43%	0.055	0.989	1.23	1	4	2	0	0	100%	1
6B4Z_A3P_A_301	98%	44%	0.058	0.984	1.02	1.13	2	2	0	0	100%	1
6MFE_A3P_A_301	98%	39%	0.059	0.984	0.98	1.4	2	6	0	0	100%	1
3AP1_A3P_A_1	100%	30%	0.036	0.989	0.96	1.8	1	5	0	0	100%	1
5T03_A3P_A_1401	100%	64%	0.04	0.988	0.73	0.67	-	1	0	0	100%	1
5T0A_A3P_B_1413	100%	56%	0.039	0.987	0.77	0.92	-	1	0	0	100%	1
2ZVQ_A3P_X_301	100%	44%	0.044	0.992	0.8	1.37	-	3	0	0	100%	1
2ZPT_A3P_X_301	100%	47%	0.045	0.993	0.88	1.17	-	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.